循环mirna与急性缺血性卒中患者3个月预后相关

IF 7.7 1区 医学 Q1 CLINICAL NEUROLOGY
Neurology Pub Date : 2025-01-14 Epub Date: 2024-12-09 DOI:10.1212/WNL.0000000000210085
Isabel Fernández-Pérez, Marta Vallverdú-Prats, Lucía Rey-Álvarez, Eva Giralt Steinhauer, Angel Ois, Elisa Cuadrado-Godia, Ana Rodriguez-Campello, Antoni Suárez-Pérez, Adrià Macias-Gómez, Carolina Soriano-Tárraga, Francisco F Purroy, Gloria Arque, Silvia Tur, Guillem Cañellas, Cristofol Vives-Bauza, Tomas Segura, Gemma Serrano-Heras, Uxue Lazcano, Joan Jiménez-Balado, Jordi Jimenez-Conde
{"title":"循环mirna与急性缺血性卒中患者3个月预后相关","authors":"Isabel Fernández-Pérez, Marta Vallverdú-Prats, Lucía Rey-Álvarez, Eva Giralt Steinhauer, Angel Ois, Elisa Cuadrado-Godia, Ana Rodriguez-Campello, Antoni Suárez-Pérez, Adrià Macias-Gómez, Carolina Soriano-Tárraga, Francisco F Purroy, Gloria Arque, Silvia Tur, Guillem Cañellas, Cristofol Vives-Bauza, Tomas Segura, Gemma Serrano-Heras, Uxue Lazcano, Joan Jiménez-Balado, Jordi Jimenez-Conde","doi":"10.1212/WNL.0000000000210085","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Post-ischemic stroke (IS) outcomes vary widely among individuals, independently of clinical factors. This variability could be related to epigenetic mechanisms that regulate biological processes involved in recovery after ischemia. While several microRNAs (miRNAs) and their target genes are implicated in the pathophysiology of IS, their role in functional outcomes remains unclear. Our aim is to identify potential miRNAs associated with the 3-month outcome in patients with IS.</p><p><strong>Methods: </strong>A discovery study was performed in patients with acute IS assessed at Hospital del Mar of Barcelona from 2009 to 2018. Main inclusion criteria were initial NIH Stroke Scale (NIHSS) score >2, hospital admission within 24 hours of IS onset, and previous functional independence. Poor 3-month outcome was defined as a modified Rankin Scale score >2. We performed miRNA next-generation sequencing on plasma samples obtained within 24 hours and performed a differential expression analysis for 2,083 miRNAs using the DESeq2 package. A replication stage was performed using real time-PCR in another multicenter cohort, with equivalent inclusion criteria and multivariate regression models. We also performed enrichment pathways analyses in both phases.</p><p><strong>Results: </strong>The discovery cohort included 215 patients with IS (mean age 74.7 ± 10.2 years, 54.9% male). Age, sex, and stroke severity (measured with the 24-hour NIHSS) were associated with the 3-month outcome (<i>p</i> < 0.05). After adjusting for these potential confounders, we found 74 miRNAs significantly associated (<i>Q</i> < 0.05) with the 3-month poor outcome. Pathway analysis revealed significant associations with pathways related to angiogenesis, neuronal morphogenesis, transforming growth factor β (TGF-β), endothelial development, and cognition. The replication included 191 patients (mean age 78.0 ± 6.0 years, 49.7% male). We analyzed 26 miRNAs selected from the discovery stage, and 5 miRNAs replicated their association with poor outcomes (<i>p</i> < 0.05, fold change >1.7): miR-376c-3p, miR-4463, miR-199a-3p, miR-584-5p, and miR-134-5p.</p><p><strong>Discussion: </strong>We identified 5 miRNAs overexpressed in patients with poor 3-month outcomes after IS, which could be involved in biological processes such as cognition, neuronal morphogenesis, and TGF-β response, suggesting a potential role in brain recovery. These findings were not evaluated in infratentorial and lacunar strokes, which limits generalizability in these particular subtypes. Further investigation is needed to explore potential applicability of these findings.</p>","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"104 1","pages":"e210085"},"PeriodicalIF":7.7000,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Circulating miRNAs Associated With 3-Month Outcome in Patients With Acute Ischemic Stroke.\",\"authors\":\"Isabel Fernández-Pérez, Marta Vallverdú-Prats, Lucía Rey-Álvarez, Eva Giralt Steinhauer, Angel Ois, Elisa Cuadrado-Godia, Ana Rodriguez-Campello, Antoni Suárez-Pérez, Adrià Macias-Gómez, Carolina Soriano-Tárraga, Francisco F Purroy, Gloria Arque, Silvia Tur, Guillem Cañellas, Cristofol Vives-Bauza, Tomas Segura, Gemma Serrano-Heras, Uxue Lazcano, Joan Jiménez-Balado, Jordi Jimenez-Conde\",\"doi\":\"10.1212/WNL.0000000000210085\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Post-ischemic stroke (IS) outcomes vary widely among individuals, independently of clinical factors. This variability could be related to epigenetic mechanisms that regulate biological processes involved in recovery after ischemia. While several microRNAs (miRNAs) and their target genes are implicated in the pathophysiology of IS, their role in functional outcomes remains unclear. Our aim is to identify potential miRNAs associated with the 3-month outcome in patients with IS.</p><p><strong>Methods: </strong>A discovery study was performed in patients with acute IS assessed at Hospital del Mar of Barcelona from 2009 to 2018. Main inclusion criteria were initial NIH Stroke Scale (NIHSS) score >2, hospital admission within 24 hours of IS onset, and previous functional independence. Poor 3-month outcome was defined as a modified Rankin Scale score >2. We performed miRNA next-generation sequencing on plasma samples obtained within 24 hours and performed a differential expression analysis for 2,083 miRNAs using the DESeq2 package. A replication stage was performed using real time-PCR in another multicenter cohort, with equivalent inclusion criteria and multivariate regression models. We also performed enrichment pathways analyses in both phases.</p><p><strong>Results: </strong>The discovery cohort included 215 patients with IS (mean age 74.7 ± 10.2 years, 54.9% male). Age, sex, and stroke severity (measured with the 24-hour NIHSS) were associated with the 3-month outcome (<i>p</i> < 0.05). After adjusting for these potential confounders, we found 74 miRNAs significantly associated (<i>Q</i> < 0.05) with the 3-month poor outcome. Pathway analysis revealed significant associations with pathways related to angiogenesis, neuronal morphogenesis, transforming growth factor β (TGF-β), endothelial development, and cognition. The replication included 191 patients (mean age 78.0 ± 6.0 years, 49.7% male). We analyzed 26 miRNAs selected from the discovery stage, and 5 miRNAs replicated their association with poor outcomes (<i>p</i> < 0.05, fold change >1.7): miR-376c-3p, miR-4463, miR-199a-3p, miR-584-5p, and miR-134-5p.</p><p><strong>Discussion: </strong>We identified 5 miRNAs overexpressed in patients with poor 3-month outcomes after IS, which could be involved in biological processes such as cognition, neuronal morphogenesis, and TGF-β response, suggesting a potential role in brain recovery. These findings were not evaluated in infratentorial and lacunar strokes, which limits generalizability in these particular subtypes. Further investigation is needed to explore potential applicability of these findings.</p>\",\"PeriodicalId\":19256,\"journal\":{\"name\":\"Neurology\",\"volume\":\"104 1\",\"pages\":\"e210085\"},\"PeriodicalIF\":7.7000,\"publicationDate\":\"2025-01-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1212/WNL.0000000000210085\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/WNL.0000000000210085","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:缺血性卒中(IS)后的预后因人而异,与临床因素无关。这种差异可能与调节缺血后恢复所涉及的生物过程的表观遗传机制有关。虽然一些微RNA(miRNA)及其靶基因与IS的病理生理学有关,但它们在功能性结果中的作用仍不清楚。我们的目的是找出与IS患者3个月预后相关的潜在miRNA:2009年至2018年期间,巴塞罗那德尔马医院对接受评估的急性IS患者进行了一项发现性研究。主要纳入标准为初始NIH卒中量表(NIHSS)评分>2分,在IS发病24小时内入院,之前功能独立。我们对24小时内获得的血浆样本进行了miRNA新一代测序,并使用DESeq2软件包对2083个miRNA进行了差异表达分析。我们在另一个多中心队列中使用实时荧光定量PCR技术进行了重复分析,并采用了相同的纳入标准和多变量回归模型。我们还在这两个阶段进行了富集路径分析:发现队列包括 215 名 IS 患者(平均年龄 74.7 ± 10.2 岁,54.9% 为男性)。年龄、性别和中风严重程度(用 24 小时 NIHSS 测量)与 3 个月的结果相关(p < 0.05)。在调整了这些潜在的混杂因素后,我们发现 74 个 miRNA 与 3 个月的不良预后显著相关(Q < 0.05)。通路分析显示,这些miRNA与血管生成、神经元形态发生、转化生长因子β(TGF-β)、内皮发育和认知相关的通路有明显的关联。复制包括 191 名患者(平均年龄 78.0 ± 6.0 岁,49.7% 为男性)。我们分析了从发现阶段选出的 26 个 miRNA,其中 5 个 miRNA 复制了它们与不良预后的关系(p < 0.05,折叠变化 >1.7):miR-376c-3p、miR-4463、miR-199a-3p、miR-584-5p 和 miR-134-5p:讨论:我们在IS术后3个月预后不佳的患者中发现了5种miRNA过表达,这些miRNA可能参与认知、神经元形态发生和TGF-β反应等生物学过程,表明它们在脑恢复中可能发挥作用。这些研究结果没有在脑室下和腔隙性脑卒中中进行评估,这限制了在这些特定亚型中的推广性。要探索这些发现的潜在适用性,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Circulating miRNAs Associated With 3-Month Outcome in Patients With Acute Ischemic Stroke.

Background and objectives: Post-ischemic stroke (IS) outcomes vary widely among individuals, independently of clinical factors. This variability could be related to epigenetic mechanisms that regulate biological processes involved in recovery after ischemia. While several microRNAs (miRNAs) and their target genes are implicated in the pathophysiology of IS, their role in functional outcomes remains unclear. Our aim is to identify potential miRNAs associated with the 3-month outcome in patients with IS.

Methods: A discovery study was performed in patients with acute IS assessed at Hospital del Mar of Barcelona from 2009 to 2018. Main inclusion criteria were initial NIH Stroke Scale (NIHSS) score >2, hospital admission within 24 hours of IS onset, and previous functional independence. Poor 3-month outcome was defined as a modified Rankin Scale score >2. We performed miRNA next-generation sequencing on plasma samples obtained within 24 hours and performed a differential expression analysis for 2,083 miRNAs using the DESeq2 package. A replication stage was performed using real time-PCR in another multicenter cohort, with equivalent inclusion criteria and multivariate regression models. We also performed enrichment pathways analyses in both phases.

Results: The discovery cohort included 215 patients with IS (mean age 74.7 ± 10.2 years, 54.9% male). Age, sex, and stroke severity (measured with the 24-hour NIHSS) were associated with the 3-month outcome (p < 0.05). After adjusting for these potential confounders, we found 74 miRNAs significantly associated (Q < 0.05) with the 3-month poor outcome. Pathway analysis revealed significant associations with pathways related to angiogenesis, neuronal morphogenesis, transforming growth factor β (TGF-β), endothelial development, and cognition. The replication included 191 patients (mean age 78.0 ± 6.0 years, 49.7% male). We analyzed 26 miRNAs selected from the discovery stage, and 5 miRNAs replicated their association with poor outcomes (p < 0.05, fold change >1.7): miR-376c-3p, miR-4463, miR-199a-3p, miR-584-5p, and miR-134-5p.

Discussion: We identified 5 miRNAs overexpressed in patients with poor 3-month outcomes after IS, which could be involved in biological processes such as cognition, neuronal morphogenesis, and TGF-β response, suggesting a potential role in brain recovery. These findings were not evaluated in infratentorial and lacunar strokes, which limits generalizability in these particular subtypes. Further investigation is needed to explore potential applicability of these findings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neurology
Neurology 医学-临床神经学
CiteScore
12.20
自引率
4.00%
发文量
1973
审稿时长
2-3 weeks
期刊介绍: Neurology, the official journal of the American Academy of Neurology, aspires to be the premier peer-reviewed journal for clinical neurology research. Its mission is to publish exceptional peer-reviewed original research articles, editorials, and reviews to improve patient care, education, clinical research, and professionalism in neurology. As the leading clinical neurology journal worldwide, Neurology targets physicians specializing in nervous system diseases and conditions. It aims to advance the field by presenting new basic and clinical research that influences neurological practice. The journal is a leading source of cutting-edge, peer-reviewed information for the neurology community worldwide. Editorial content includes Research, Clinical/Scientific Notes, Views, Historical Neurology, NeuroImages, Humanities, Letters, and position papers from the American Academy of Neurology. The online version is considered the definitive version, encompassing all available content. Neurology is indexed in prestigious databases such as MEDLINE/PubMed, Embase, Scopus, Biological Abstracts®, PsycINFO®, Current Contents®, Web of Science®, CrossRef, and Google Scholar.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信